Last reviewed · How we verify
NCT03681054: eMOM
Dietary Management of Gestational Diabetes
NA trial testing Carbohydrate restricted diet in Diabetes, Gestational in 42 participants. Participants enrolled and being followed up; not accepting new ones.
5 June 2020
Quick facts
| Lead sponsor | Helsinki University Central Hospital |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 42 |
| Start date | 3 December 2018 |
| Primary completion | 5 June 2020 |
| Estimated completion | 30 December 2027 |
| Sites | 1 location across Finland |
Drugs / interventions tested
- Carbohydrate restricted diet
- Plant-protein based diet
Conditions studied
- Diabetes, Gestational — all drugs for Diabetes, Gestational →
- Dietary Modification — all drugs for Dietary Modification →
- Glucose Intolerance During Pregnancy — all drugs for Glucose Intolerance During Pregnancy →
- Body Composition — all drugs for Body Composition →
Sponsor
Helsinki University Central Hospital
Who can join
Eligibility, female only, with Diabetes, Gestational or Dietary Modification. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
eMOM is a randomized, controlled trial to compare the effects of two different dietary interventions during pregnancy. The comparison is based on tissue glucose content (using continuous glucose monitoring system) in pregnant women and on neonate body composition. The recruited women (n=60) have been diagnosed with gestational diabetes mellitus, and are of Caucasian origin. Of the study diets, one is moderately carbohydrate restricted and the other one is high on plant-based protein with an emphasis on healthy Nordic foods. The study has two two-week study periods that are carried out on approximately gestational weeks 24-28 (period I) and 34-36 (period II). Continuous glucose monitoring and other measurements (accelerometer, 3-day food record, gut microbiota, serum lipids, metabolomics, epigenetics etc.) are done during these study periods. At the beginning of the study, before study period I, the participants are randomized to either one of the intervention diets. The first study period consists of a crossover phase in which the participants receive three days' worth of food according to one of the intervention diets (according to the randomization) after which there is a three-day wash-out period. After the wash-out period, the participants receive three days' worth of food according to the other diet. After the first study period, a nutritionist advises the lastly followed intervention diet to the participant and the diet is followed until delivery. To ensure the diet is followed, the participants gets at least three personal face-to-face counseling sessions, phone calls, mobile reminders, recipes and food items. After delivery, the infant's body composition, epigenetic markers of cord blood and placenta, gut microbiome and urine metabolomics are measured.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Short-term effect of plant-based Nordic diet versus carbohydrate-restricted diet on glucose levels in gestational diabetes - the eMOM pilot study.
Markussen LT, Kivelä J, Lindström J, Ashrafi RA, et al · · 2023 · cited 4× · PMID 37452403 · DOI 10.1186/s40795-023-00744-7 -
Glycemic control in women with GDM: insights from a randomized controlled pilot trial on plant-based Nordic healthy diet versus moderately carbohydrate restricted diet.
Markussen LT, Kivelä J, Lindström J, Ollikainen M, et al · · 2025 · PMID 39815337 · DOI 10.1186/s40795-024-00988-x -
Glycemic control in women with GDM: Insights from a randomized controlled pilot trial on plant-based Nordic Healthy diet versus moderately carbohydrate restricted diet
Markussen LT, Kivelä J, Lindström J, Ollikainen M, et al · · 2023 · DOI 10.21203/rs.3.rs-3705373/v1 -
Short-term effect of plant-based Nordic diet versus carbohydrate-restricted diet on glucose levels in gestational diabetes – the eMOM pilot study
Markussen LT, Kivelä J, Lindström J, Ashrafi RA, et al · · 2023 · DOI 10.21203/rs.3.rs-2502889/v1
Verify or expand the search:
- PubMed search for NCT03681054
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Carbohydrate restricted diet
Trials testing the same drug.
- NCT03679260 — Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active Surveillance · Phase 2 · completed
- NCT03542071 — Dietary Management of Gestational Diabetes in Obese Pregnant Women · NA · terminated
Other recruiting trials for Diabetes, Gestational
Currently open trials in the same condition.
- NCT05840497 — Effect of Strength-resistance Exercise in the Reduction of Gestational Diabetes in Pregnant Women with Overweight or Obe · NA · recruiting
- NCT04542148 — Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes · Phase 2 · active not recruiting
- NCT03607799 — A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes · NA · active not recruiting
- NCT04060056 — Westlake Precision Birth Cohort · NA · active not recruiting
Other Helsinki University Central Hospital trials
Trials by the same sponsor.
- NCT07423637 — The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Control and Comorbidities, and Cost-effectivene · NA · not yet recruiting
- NCT07462559 — KF2025#1 Trial: Ketamine, Cannabidiol and Cobicistat Interaction Study · Phase 1 · not yet recruiting
- NCT07458984 — FMT Capsules for rCDI · Phase 3 · not yet recruiting
- NCT07001423 — ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly · NA · recruiting
- NCT07155629 — Neoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic Cancer · Phase 3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03681054 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Helsinki University Central Hospital
- Last refreshed: 24 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03681054.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing